Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong Sun

Showing results (331-340 of 336) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 336 results.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Patterns (New York, N.Y.)|October 24, 2022
SELFIES and the future of molecular string representationsMario Krenn, Qianxiang Ai, Senja Barthel, et al.
Cancer Cell|November 8, 2024
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell|April 28, 2026
Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapesLena Jassowicz, Fangyoumin Feng, Rolf Warta, et al.
Cancer Cell|September 8, 2023
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
The Journal of Chemical Physics|July 17, 2020
Recent developments in the PySCF program packageQiming Sun, Xing Zhang, Samragni Banerjee, et al.
Pageof 34

Showing results (331-340 of 336) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 336 results.
Nature|July 22, 2021
EGFR activation limits the response of liver cancer to lenvatinibHaojie Jin, Yaoping Shi, Yuanyuan Lv, et al.
Patterns (New York, N.Y.)|October 24, 2022
SELFIES and the future of molecular string representationsMario Krenn, Qianxiang Ai, Senja Barthel, et al.
Cancer Cell|November 8, 2024
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapyChen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell|April 28, 2026
Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapesLena Jassowicz, Fangyoumin Feng, Rolf Warta, et al.
Cancer Cell|September 8, 2023
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
The Journal of Chemical Physics|July 17, 2020
Recent developments in the PySCF program packageQiming Sun, Xing Zhang, Samragni Banerjee, et al.
Pageof 34